Functional domains of the very low density lipoprotein receptor: molecular analysis of ligand binding and acid-dependent ligand dissociation mechanisms
Abstract
The very low density lipoprotein (VLDL) receptor is closely related in structure to the low density lipoprotein receptor. The ectodomain of these endocytic receptors is composed of modules which include clusters of cysteine-rich class A repeats, epidermal growth factor (EGF)-like repeats, tyrosine-tryptophan-threonine-aspartic acid (YWTD) repeats and an O-linked sugar domain. To identify important functional regions within the ectodomain of the VLDL receptor, we produced a mutant receptor in which the EGF, YWTD and O-linked sugar domains were deleted. Cells transfected with the mutant receptor were able to bind and internalize (125)I-labeled receptor associated protein (RAP). In contrast to the wild-type receptor, however, RAP did not dissociate from the mutant receptor and consequently was not degraded. Immunofluoresence data indicated that once bound to the mutant receptor, fluorescent-labeled RAP co-localized with markers of the endosomal pathway, whereas, in cells expressing the wild-type receptor, RAP fluorescence co-localized with lysosomal markers. Thus this deleted region is responsible for ligand uncoupling within the endosomes. To identify regions responsible for ligand recognition, soluble receptor fragments containing the eight cysteine-rich class A repeats were produced. (125)I-RAP and (125)I-labeled urokinase-type plasminogen activator:plasminogen activator inhibitor type I (uPA:PAI-1) complexes bound to the soluble fragment with K(D, app) values of 0.3 and 14 n…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LRAD3 lacks the EGF and β-propeller domains found in extracellular portions of LDL receptor family members.
“LRAD3 also lacks the EGF and β-propeller domains that are found in the extracellular portions of LDL receptor family members which are important for pH-induced uncoupling of ligands within acidic endosomal compartments (Davis et al., 1987; Mikhailenko et al., 1999; Rudenko et al., 2002).”
From LRAD3, A Novel Low-Density Lipoprotein Receptor Family Member That Modulates Amyloid Precursor Protein Trafficking (2011) · cites this paper as Mikhailenko et al., 1999
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 45 · Cited by 48
- Authors
- Mikhailenko, I., Considine, W., Argraves, K. M., Loukinov, D., Hyman, B. T., & Strickland, D. K.
- Affiliations
- American Red Cross (US)
- Massachusetts General Hospital (US)
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1999-10-01
- Volume
- 112
- Issue
- 19
- Pages
- 3269-3281
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W1924359254
- Cited by
- 48
- References
- 45
- Citations by year
- 2022: 1 · 2019: 1 · 2016: 1 · 2015: 1
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cell Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL50784, R01HL050784, P01HL5710)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- VLDLR, LDL receptor, receptor ectodomain, receptor-associated protein, ligand binding, EGF-like repeats, urokinase, plasminogen activator inhibitor-1, allosteric mechanism, receptor internalization, lysosomal degradation, endocytic receptor
- MeSH terms
- Acids, Allosteric Regulation, Animals, Endocytosis, Epidermal Growth Factor, Fluorescent Antibody Technique, Cricetinae, Humans, Iodine Radioisotopes, Ligands, Peptide Fragments, Protein Binding, Radioligand Assay, Receptors, LDL, Recombinant Fusion Proteins, Transfection, Transferrin, Urokinase-Type Plasminogen Activator, Mutagenesis, CHO Cells, Gene Deletion, Plasminogen Activator Inhibitor 1, Protein Structure, Tertiary, DNA Primers, DNA, Complementary, COS Cells, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review